HES7 is a bHLH transcriptional repressor that functions as a core component of the segmentation clock, essential for coordinated somite formation 1. It represses transcription from N box- and E box-containing promoters and is dynamically expressed in the presomitic mesoderm under Notch signaling control 1. HES7 oscillates with species-specific periods: 2-3 hours in mice versus 5-6 hours in humans, reflecting differential biochemical reaction kinetics rather than sequence differences 2. These oscillations are synchronized across neighboring cells and coupled with Notch and FGF signaling to generate the oscillatory networks that constitute the core segmentation clock 3. Perturbation of HES7 oscillatory dynamics, such as through altered Dll1 expression timing, impairs somite segmentation and causes vertebral fusion 4. In humans, HES7 mutations are associated with spondylocostal dysostosis 4, an autosomal recessive disorder affecting axial skeleton development 5. Recent pluripotent stem cell models demonstrate HES7's critical role in human somitogenesis and have enabled investigation of disease-causing mutations 5. Additionally, HES7 may suppress prostate tumorigenesis through epigenetic regulation 6, suggesting roles beyond developmental biology.